Stock EPRX EUPRAXIA PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Eupraxia Pharmaceuticals Inc.

Equities

EPRX

CA29842P1053

Delayed Toronto S.E.
Other stock markets
 09:37:31 2024-06-03 am EDT 		5-day change 1st Jan Change
3.74 CAD +2.47% Intraday chart for Eupraxia Pharmaceuticals Inc. -2.09% -30.35%
May. 23 Eupraxia Pharmaceuticals Expanding RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT
May. 23 Eupraxia Pharmaceuticals Inc. Brief: Announcing Expansion of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis MT

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
EUPRAXIA PHARMACEUTICALS INC.
Other Biotechnology & Medical Research
-4.20%-6.41%-32.03%-47.33% - 95.3M
Neutral
Bearish
Bearish
  1. Stock Market
  2. Equities
  3. EPRX Stock
  4. Charts Eupraxia Pharmaceuticals Inc.
  5. Relative Strength Chart